Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease

    NEJM Evidence Date published:

  • Correlation of Urinary Soluble CD163 Levels With Disease Activity and Treatment Response in IgA Nephropathy

    Kidney International Reports Date published:

  • Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

    The Lancet Diabetes & Endocrinology Date published:

  • The Effects of Anti-Inflammatory Agents on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomised Controlled Clinical Trials

    Heart, Lung and Circulation Date published:

  • Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes

    Journal of the American College of Cardiology Date published:

  • Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial

    Journal of the American College of Cardiology Date published:

  • Selonsertib in Patients with Diabetic Kidney Disease

    Journal of the American Society of Nephrology Date published:

  • Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial

    European Journal of Heart Failure Date published:

  • Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

    Nature Medicine Date published:

  • Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial

    Diabetes, Obesity and Metabolism Date published:

  • Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial

    Nephrology Dialysis Transplantation Date published:

  • Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial

    Diabetes, Obesity and Metabolism Date published:

  • Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

    New England Journal of Medicine Date published:

  • Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From Four Large-Scale Placebo-Controlled Outcome Trials

    Circulation Date published:

  • Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS)

    American Journal of Respiratory and Critical Care Medicine Date published:

  • #456 Efficacy and safety of iptacopan in patients with primary IgA nephropathy: interim analysis results of the Phase 3 APPLAUSE-IgAN study

    Nephrology Dialysis Transplantation Date published: